TCG Crossover Management, LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$513.0B
Holdings
22
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (22 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | OPHTEURIVERIC BIO INC | 5,141,118 | $125K | 0.00% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 3,631,042 | $39K | 0.00% | |
| 3 | GONGERON CORP | 17,765,213 | $38K | 0.00% | |
| 4 | MDGLMADRIGAL PHARMACEUTICALS INC | 149,917 | $36K | 0.00% | |
| 5 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $31K | 0.00% | |
| 6 | VTYXVENTYX BIOSCIENCES, INC | 815,724 | $27K | 0.00% | |
| 7 | CBAYUSDCYMABAY THERAPEUTICS INC | 3,048,257 | $26K | 0.00% | |
| 8 | KALVKALVISTA PHARMACEUTICALS, INC | 3,395,495 | $26K | 0.00% | |
| 9 | —VECTIVBIO HOLDING AG | 3,113,600 | $26K | 0.00% | |
| 10 | AVTEAEROVATE THERAPEUTICS INC | 1,081,274 | $21K | 0.00% | |
| 11 | DYNDYNE THERAPEUTICS, INC | 1,650,150 | $19K | 0.00% | |
| 12 | KURAKURA ONCOLOGY INC | 1,423,642 | $17K | 0.00% | |
| 13 | VRDNVIRIDIAN THERAPEUTICS, INC | 663,610 | $16K | 0.00% | |
| 14 | SLNSILENCE THERAPEUTICS PLC | 2,104,875 | $13K | 0.00% | |
| 15 | IMVTIMMUNOVANT, INC | 654,853 | $10K | 0.00% | |
| 16 | GPCRSTRUCTURE THERAPEUTICS INC | 350,000 | $8K | 0.00% | |
| 17 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $8K | 0.00% | |
| 18 | MRUSMERUS BV | 300,000 | $5K | 0.00% | |
| 19 | CABACABALETTA BIO, INC | 486,795 | $4K | 0.00% | |
| 20 | ACRSACLARIS THERAPEUTICS INC | 529,839 | $4K | 0.00% | |
| 21 | CCCCC4 THERAPEUTICS, INC. | 1,250,000 | $3K | 0.00% | |
| 22 | NVLSEURALPINE IMMUNE SCIENCES INC | 253,069 | $1K | 0.00% |